Abstract
Clinical evaluations of Sulbactam Cefoperazone (SBT/CPZ, Sulpemzome®) in various infections in the field of oral surgery were carried out.Sulbactam/Ceforperazone was administered to 51 patients with various infections. Sulbactam/Cefoperazone wasadministered by intravenous injection at a daily dose of 2 g (1 g × 2 times). Cases consistedof31 with maxillary ostitis, 3 phlegmone of the floor of the mouth, 4 pericoronitis, 2odontgenic maxillary sinuitis, 4 buccal abscess, 3 infection of post operative maxillary cyst, 1parotitis, 1 submaxillary limphadenitis and 2 peritonsillitis. The clinical effects obtained insubjective judgement were exellent in 25 cases, good in 22, fair in 4 and poor in none. The clinical effects obtained in judgement by point were excellent in 14 cases, good in 33 and poor in 4.The effective rate of which was 92.2%, the same as the former.As for side effects, stomatic discomfort appeared in one case.In the laboratory examination, elevation of s-GOT was observed in A patient, andelevation of BUN was observed in another patient. The results indicated theusefullness of Sulbactam/Cefoperazone in the treatment of various infections in the field of oralsurgery.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Japanese Journal of Oral & Maxillofacial Surgery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
